Birchtech (BCHT) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
13 May, 2026Executive summary
Q1 2026 revenues rose 32% year-over-year to $4.24 million, driven by growth in water treatment and air business segments, with product sales up and licensing revenue down.
Completed uplisting to NYSE American and raised $16.44 million in gross proceeds, significantly strengthening liquidity and expanding the investor base.
Advanced enforcement of a $78 million patent infringement judgment, with collection efforts underway and post-judgment interest accruing, though realization remains uncertain due to ongoing appeals.
Launched SEA-IX nuclear-grade ion exchange resin, securing $1 million in initial orders and expanding the water solutions portfolio.
Appointed Michael Mioska as CFO in May 2026 to support growth and M&A activities.
Financial highlights
Product sales increased to $4.19 million from $2.68 million year-over-year, while licensing revenue dropped to $0 from $525,000.
Gross profit rose to $1.4 million from $1.2 million, with gross margin at approximately 33%.
Net loss narrowed to $1.3 million ($0.06 per share) from $1.7 million ($0.09 per share) year-over-year.
Adjusted EBITDA loss improved to $(1.0) million from $(1.2) million.
Cash balance at March 31, 2026 was $14.7 million, up from $2.2 million at year-end 2025, with no debt.
Outlook and guidance
Plans to collect on the $78 million judgment, convert more licensed utilities to recurring product supply, and advance offtake agreements for the first carbon rejuvenation facility.
Expects continued revenue growth in both air and water segments, with activated carbon sales comprising a larger share of total revenue.
Anticipates the water business, especially R&D and rejuvenation, to become a profit center in 2026.
Management expects sufficient liquidity for at least the next twelve months, supported by offering proceeds and anticipated revenues.
Positioned to capture growth in the water treatment sector, leveraging new laboratory investments and regulatory tailwinds.
Latest events from Birchtech
- Recurring revenues and legal wins fuel expansion into the $1.5B water treatment market.BCHT
Corporate presentation7 Apr 2026 - Q4 2025 product revenues rose 19.8%, with a stronger balance sheet and new commercial wins.BCHT
Q4 202531 Mar 2026 - Poised for major growth in 2026 with new water treatment solutions and strong regulatory tailwinds.BCHT
IAccess Alpha Virtual Best Ideas Spring Investment Conference 202610 Mar 2026 - High-margin air and water treatment solutions, strong IP wins, and rapid water market expansion.BCHT
Investor presentation5 Mar 2026 - Public offering aims to fund operations and water treatment expansion, but risks and dilution are high.BCHT
Registration Filing12 Feb 2026 - Raising $17.7M to fund growth in air and water purification amid regulatory and financial risks.BCHT
Registration Filing3 Feb 2026 - Q3 revenue and profit declined, but debt was repaid and a $57.1M patent win supports growth.BCHT
Q3 202430 Jan 2026 - IPO seeks $17.7M–$20.5M to fund growth in air and water purification amid regulatory risks.BCHT
Registration Filing13 Jan 2026 - Q4 revenue up 37% to $5.6M; water business launched; strong IP and growth outlook.BCHT
Q4 202427 Dec 2025